Denali Therapeutics Inc. DNLI Business Segments — Personnel related general and administrative expenses
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Denali Therapeutics Inc. in its filing.
Tagged under the XBRL concept dnli:PersonnelRelatedGeneralAndAdministrativeExpense.
The official record: Denali Therapeutics Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Denali Therapeutics Inc.'s business segments — personnel related general and administrative expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Denali Therapeutics Inc.'s business segments — personnel related general and administrative expenses?
- Denali Therapeutics Inc. (DNLI) reported business segments — personnel related general and administrative expenses of $22.56M in Q1 2026.
- How has Denali Therapeutics Inc.'s business segments — personnel related general and administrative expenses changed year-over-year?
- Denali Therapeutics Inc.'s business segments — personnel related general and administrative expenses increased by 20.4% year-over-year, from $18.74M to $22.56M.
- What is the long-term trend for Denali Therapeutics Inc.'s business segments — personnel related general and administrative expenses?
- Over 3 years (2022 to 2025), Denali Therapeutics Inc.'s business segments — personnel related general and administrative expenses has grown at a 10.4% compound annual growth rate (CAGR), from $64.15M to $86.23M.
- What does business segments — personnel related general and administrative expenses mean?
- Represents compensation and benefits for non-research staff, including management, legal, finance, and administrative support. This metric measures the overhead cost required to support the company's corporate operations. Stable or declining ratios of these expenses relative to total operating expenses indicate effective administrative cost management.